{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:52:51Z","timestamp":1762674771046,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prostate tuberculosis is a common form of urogenital tuberculosis that occurs in men. Clinical and imaging manifestations of prostate tuberculosis are atypical, which often need to be differentiated from benign prostatic hyperplasia, a prostate malignant tumor, and a urinary tract infection. Although prostate-specific membrane antigen (PSMA) is considered a specific biomarker for prostate cancer, it is also found within tuberculosis tissues that may be stimulated by angiogenic factors. An abnormal PSMA uptake on positron emission tomography combined with computed tomography (PET\/CT) should eliminate the possibility of tuberculosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>In this study, we reported a case of a 51-year-old man with an elevated erythrocyte sedimentation rate (ESR) but a normal prostate-specific antigen (PSA) value. 2-Deoxy-2-[fluorine-18]-fluoro-D-glucose (<jats:sup>18<\/jats:sup>F-FDG) and [fluorine-18]-prostate-specific membrane antigen (<jats:sup>18<\/jats:sup>F-PSMA) PET\/CT scans were performed for further evaluation. The prostate showed a high fluoro-D-glucose (FDG) uptake but a slight PSMA uptake. Multiple osteolytic bone destruction and lymph nodes with an increased FDG uptake but a mild PSMA uptake were observed throughout the body. Systemic tuberculosis was diagnosed based on the prostate biopsy and the positive result of the T-cell spot test regarding tuberculosis infection. After 6 months of standard anti-tuberculosis treatment, the patient experienced symptom relief.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the case of a urinary tract infection, where the prostate shows high FDG uptake lesions with perilesional abscess, a mildly increased PSMA uptake, a low PSA value, a high ESR, and relevant clinical symptoms, tuberculosis should be considered and laboratory tests are required, especially when symptoms are relieved after successful anti-tuberculosis therapy. The final confirmation of the diagnosis still relies on pathological examination.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1430300","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:14:50Z","timestamp":1723612490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Systemic tuberculosis with prostate involvement mimicking prostate cancer with multiple metastases on 18F-FDG and 18F-PSMA PET\/CT"],"prefix":"10.3389","volume":"11","author":[{"given":"Xinyao","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lele","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.TNMI7-0015-2016","article-title":"Urogenital tuberculosis. Microbiology","volume":"5","author":"Figueiredo","year":"2017","journal-title":"Spectrum"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101312","DOI":"10.1016\/j.eucr.2020.101312","article-title":"Pauci-symptomatic disseminated tuberculosis revealed by an increase in the specific antigen of the prostate","volume":"33","author":"Kadouri","year":"2020","journal-title":"Urol Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00259-021-05486-x","article-title":"68Ga-labeled ODAP-urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent","volume":"49","author":"Duan","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0090-4295(78)90232-7","article-title":"Tuberculosis of prostate","volume":"11","author":"Sporer","year":"1978","journal-title":"Urology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"20220101","DOI":"10.1259\/bjrcr.20220101","article-title":"A rare case of disseminated genitourinary tract tuberculosis complicated by emphysematous prostatitis and seminal vesicle abscess","volume":"9","author":"Kundasamy","year":"2023","journal-title":"BJR Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e36172","DOI":"10.1097\/MD.0000000000036172","article-title":"Prostate tuberculosis mimicking prostate cancer: case report and literature review","volume":"102","author":"Li","year":"2023","journal-title":"Medicine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00000478-199503000-00002","article-title":"The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases","volume":"19","author":"Wojno","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0090-4295(99)80118-6","article-title":"Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory","volume":"45","author":"Kahane","year":"1995","journal-title":"Urology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-200209000-00006","article-title":"Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer","volume":"26","author":"Shah","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.30699\/ijp.2020.113544.2229","article-title":"Diagnostic value of cytokeratin 34 beta E12 (Ck34\u03b2E12) and \u03b1-Methylacyl-CoA racemase (AMACR) Immunohistochemical expression in prostatic lesions","volume":"15","author":"Hasan","year":"2020","journal-title":"Iran J Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2559.2005.02188.x","article-title":"Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature","volume":"47","author":"Varma","year":"2005","journal-title":"Histopathology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2559.2004.01930.x","article-title":"Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker","volume":"45","author":"Jiang","year":"2004","journal-title":"Histopathology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1746-1596-5-83","article-title":"Diagnostic utility of \u03b1-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer","volume":"5","author":"Kumaresan","year":"2010","journal-title":"Diagn Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1067\/j.cpradiol.2020.10.005","article-title":"Multimodality imaging of genitourinary tuberculosis","volume":"50","author":"Radwan","year":"2021","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref15","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S","article-title":"Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases","volume":"82","author":"Bostwick","year":"1998","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/RLU.0000000000002910","article-title":"68Ga-prostate-specific membrane antigen uptake in cerebral tuberculosis","volume":"45","author":"Wong","year":"2020","journal-title":"Clin Nucl Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/ijnm.IJNM_56_20","article-title":"Spinal tuberculosis mimicking as prostate cancer metastases in Ga-68 prostate-specific membrane antigen positron-emission tomography\/computed tomography","volume":"35","author":"Gupta","year":"2020","journal-title":"Indian J Nuclear Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/a-1312-6148","article-title":"68Ga-PSMA uptake in pulmonary tuberculosis: a pitfall in prostate cancer PET imaging","volume":"60","author":"Liu","year":"2021","journal-title":"Nuklearmedizin Nuclear Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.23736\/S1824-4785.16.02680-7","article-title":"68Ga-citrate PET\/CT in tuberculosis: a pilot study","volume":"63","author":"Vorster","year":"2019","journal-title":"Q J Nuclear Med Mol Imaging"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1097\/RLU.0000000000004122","article-title":"Primary solitary tuberculosis in the hepatic round ligament detected by 68Ga-FAPI PET\/CT","volume":"47","author":"Deng","year":"2022","journal-title":"Clin Nucl Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/RLU.0000000000003917","article-title":"68Ga-FAPI and 18F-PET\/CT images in intestinal tuberculosis","volume":"47","author":"Zheng","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1430300\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:14:54Z","timestamp":1723612494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1430300\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":22,"alternative-id":["10.3389\/fmed.2024.1430300"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1430300","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"article-number":"1430300"}}